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Abstract
Hendra virus (HeV) continues to cause fatal infection in horses and threaten infection in
close-contact humans in eastern Australia. Species of Pteropus bats (flying-foxes) are the nat-
ural reservoir of the virus. We caught and sampled flying-foxes from a multispecies roost in
southeast Queensland, Australia on eight occasions between June 2013 and June 2014. The
effects of sample date, species, sex, age class, body condition score (BCS), pregnancy and lac-
tation on HeV antibody prevalence, log-transformed median fluorescent intensity (lnMFI)
values and HeV RNA status were assessed using unbalanced generalised linear models. A
total of 1968 flying-foxes were sampled, comprising 1012 Pteropus alecto, 742 P. poliocephalus
and 214 P. scapulatus. Sample date, species and age class were each statistically associated with
HeV RNA status, antibody status and lnMFI values; BCS was statistically associated with HeV
RNA status and antibody status. The findings support immunologically naïve sub-adult P.
alecto playing an important role in maintaining HeV infection at a population level. The bio-
logical significance of the association between BCS and HeV RNA status, and BCS and HeV
antibody status, is less clear and warrants further investigation. Contrary to previous studies,
we found no direct association between HeV infection and pregnancy or lactation. The find-
ings in P. poliocephalus suggest that HeV exposure in this species may not result in systemic
infection and virus excretion, or alternatively, may reflect assay cross-reactivity with another
(unidentified) henipavirus.
Introduction
First described in 1994 [1], Hendra virus (HeV) (Henipavirus: Paramyxoviridae) continues to
cause fatal equine infection and pose a threat of infection in close-contact humans in eastern
Australia [2–4]. As of 30 April 2019, there have been 103 confirmed or possible equine cases
and seven human cases of HeV reported, with case fatality rates around 90% and 60%, respect-
ively [5]. Equine cases occur near-annually; the most recent human case was in 2009, puta-
tively reflecting heightened and targeted awareness and risk mitigation communication by
animal and public health authorities. In addition, two canine infections (both associated
with equine cases) have been reported [6]. Pteropus spp. bats (colloquially known as flying-
foxes in Australia) are the natural host of the virus [7–9], with P. alecto and P. conspicillatus
shown to be the primary reservoir [10–12].
An effective vaccine for horses is available [13], and vaccination is regarded by animal
health authorities as the single most effective means of preventing infection [14]. However,
vaccine uptake has been limited, and minimizing contact between horses and flying-foxes
remains a primary risk management strategy for many horse owners [15, 16]. To be effective,
such strategies need to be underpinned by a comprehensive understanding of drivers and
dynamics of HeV infection in flying-foxes [9, 17, 18].
Early studies of the ecology of infection in flying-foxes focused on individual animal ser-
ology and demonstrated that neutralizing antibodies to HeV were taxonomically and geo-
graphically widespread in flying-foxes [19]. Various studies have shown a higher antibody
prevalence in older flying-foxes, in pregnant and lactating flying-foxes, and in black flying-
foxes (Pteropus alecto) [19–22]. Later studies sought viral RNA using qRT PCR on pooled
urine samples collected under roosting flying-foxes. These studies progressively demonstrated
the limited genetic diversity of HeV [23], spatial and temporal heterogeneity in strain occur-
rence [23], higher probability of detection in black and spectacled flying-foxes [24], and
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spatiotemporal patterns of excretion [9, 25]. More recently, qRT
PCR approaches have been used in individual animal studies,
confirming black flying-foxes as an epidemiologically significant
host species, and establishing urine as a primary route of excre-
tion [11, 12].
While these studies have cumulatively provided information
on which to base and refine exposure risk management strategies,
the relative infection risk posed by various flying-fox cohorts over
time, and the relationship between infection status and antibody
status, has remained an enduring knowledge gap. In this longitu-
dinal study, we describe, compare and contrast both serologic and
molecular findings in samples from individual bats to better
understand HeV infection and immune dynamics in flying-foxes
and to better inform equine exposure risk management. Our aim
is to identify key epidemiological variables significantly associated
with HeV infection in flying-foxes.
Methods
Ethics statement
Fieldwork was approved under the (then) Queensland
Department of Agriculture, Fisheries and Forestry Animal
Ethics Committee Permit SA 2011/12/375 and the Queensland
Department of Environment, Heritage and Protection Scientific
Purposes Permits WISP05810609 and WISP14100614. Capture
and sampling were undertaken by trained and experienced
teams including at least one veterinarian.
Capture and sampling
A parkland roost in the town of Boonah in southeast Queensland
(27.992°S, 152.681°E) was purposively selected as the sampling
location for several related studies because of its apparent
permanency, substantial size, species diversity, accessibility and
proximity to the Biological Sciences Laboratory (BSL) in
Brisbane. Between June 2013 and June 2014, flying-foxes were
non-randomly captured and sampled approximately every
2 months as described by Edson et al. [12]. Briefly, animals
were captured using mist nets as they returned to roost pre-dawn;
each animal was promptly extracted from the net and placed indi-
vidually in a clean pillow case tied to a horizontal line pending
anaesthesia and sample collection. Each bat was subsequently
anaesthetised using the inhalation agent isoflurane and medical
oxygen [26]. Capture and sampling events typically occurred
over 7–10 successive days, with the mid-point taken as the sample
date for analytical purposes. Species, sex, age class ( juvenile, sub-
adult, adult), bodyweight (g), forearm length (mm), body condi-
tion score (BCS) (1–5) and reproductive status (palpably preg-
nant, lactating) were recorded. Age class was based on
morphometrics and sexual maturity, with juvenile <12 months,
sub-adult 12–24 months and adult >24 months [12]. BCS was
based on palpated pectoral muscle mass, with 1 = poor, 2 = less
than fair, 3 = fair, 4 = greater than fair, 5 = good [12]. Bats were
also classified by birth year cohort around the October mid-point
of the annual birth pulse [27] (Fig. 1). Thus, we sampled bats
born before 30 September 2011 (adults), bats born in the 2011
birth cohort (c11) which were ∼20 months (sub-adults) at the
beginning of the study and transitioned to adults during the
study, bats born in the 2012 birth cohort (c12) which were ∼8
months ( juvenile) at the beginning of the study and ∼19 months
(sub-adults) at the end of the study, and bats born in the 2013
birth cohort (c13) which were born during the study period
and ∼7 months ( juvenile) at the end. Adult bats could not be
assigned a birth year cohort because of the limitations of ageing
techniques based on morphometrics and sexual maturity beyond
24 months. One millilitre of blood was collected from the wing
(cephalic) vein of each bat using a 25 G needle and 2 ml syringe,
and immediately placed in a serum tube (1.3 ml BD Serum
Tube®). Blood was allowed to clot for 6–24 h prior to centrifuga-
tion and separation of serum and packed haemocytes. Urine was
collected into one or more plain 2 ml cryovials by gentle trans-
abdominal compression of the bladder, and samples retained on
ice prior to processing. Nasal, oral and rectal swabs (551C
Copan® Minitip Flocked Swab) (plus vaginal or preputial swabs
when a urine sample was not obtained) were taken, immediately
placed in 500 µl of phosphate-buffered saline (PBS) and kept on
ice prior to processing. All bats were monitored post-anaesthesia
until they regained consciousness, and after a further recovery
period of 30–60 min, released at the point of capture.
P. alecto were preferentially targeted to facilitate investigation
of infection dynamics because of the reported higher HeV detec-
tion rate in this species [9, 11, 12]. P. poliocephalus and P. scapu-
latus were included to enable comparative sero-epidemiology.
Sample processing and testing
Serologic testing for anti-HeV antibodies
Serology was performed using a multiplex microsphere technique
previously described by Bossart et al. [28]. Briefly, a pre-
determined number of magnetic carboxylated microsphere
beads (Fisher Biotec Pty Ltd, Australia) were selected for a protein
coupling reaction. The HeV soluble G protein [29] was coupled to
the bead set and mixed with the test sera at a dilution of 1:100.
Bound antibody was detected using biotinylated Protein A at
1:500 and biotinylated Protein G at 1:250 (Pierce, USA); the
reporter streptavidin-phycoerythrin was added at 1:1000
(Qiagen Pty Ltd, Australia). The beads were analysed using a
Luminex MAGPIX system, and results were recorded as median
fluorescent intensity (MFI).
The likelihood that an individual MFI value was positive or
negative was determined by calculating cut-offs using Bayesian
mixture models following Peel et al. [30] and Chowdhury et al.
[31]. However, after log-transformation of MFI values, the sero-
negative and seropositive distributions remained positively and
negatively skewed, respectively, indicating that normal distribu-
tion models were inappropriate. The mixture model was therefore
fitted with a shifted-Gompertz and a Gompertz distribution in R
[32]. Conservative species-specific cut-offs were calculated (P.
alecto, 1636; P. poliocephalus, 992; P. scapulatus, 1339) so that
individuals with MFI values above the cut-off had a probability
in excess of 95% of having anti-HeV antibodies. Natural loga-
rithm MFI (lnMFI) values have previously been found to correlate
strongly with neutralizing antibody titre [28, 30, 33], and are a
robust indication of immune dynamics at a population level.
Further details, including potential limitations of this assay, are
provided as Supplementary information (Text S1, Table S1, Figs
S1 and S2).
Molecular testing for HeV RNA
The quantitative RT-PCR data reported in Edson et al. [12] are
re-analysed in this paper after pairing with serological data.
Briefly, they added 50 µl of urine, serum, packed haemocytes
and PBS from nasal, oral and rectal swab samples (plus vaginal
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or preputial swabs when a urine sample was not obtained)
individually to 130 µl of lysis solution (MagMAX, Ambion,
Texas, Cat AM8500) to inactivate virus particles and preserve
RNA for PCR screening. Total nucleic acid was extracted using
a magnetic bead-based nucleic acid extraction kit (MagMAX-96
viral RNA isolation system, Ambion, Texas, Cat AM1836-5) run
on a magnetic particle handling system (Kingfisher KF-96,
Thermo-Scientific, Finland) according to the manufacturer’s
instructions. Using the AgPath-ID One-Step RT-PCR Kit (Life
Technologies, Melbourne, Australia), 5 µl of nucleic acid extract
was added to 20 µl of mastermix. Forward and reverse primers
and probe targeting a 69 base pair region on the M gene were
used [34]. Positive and negative controls were included in each
run. Assays were run on a 7500 Fast Real-Time PCR System
(Applied Biosystems) in standard mode for a total of 45 cycles
in accordance with the manufacturer’s instructions for the mas-
termix. As described in Edson et al. [12], a subset of individuals
(621/1968) had all sample types tested; for the remainder, serum
and urine (or vaginal or preputial swabs when urine was not
obtained) were used as a screening panel. An individual was con-
sidered ‘RNA-positive’ if any sample type yielded a positive PCR
result (a Ct value <40), and ‘RNA-negative’ otherwise [34].
However, Edson et al. [12] found that only 9/16 individuals posi-
tive on their urine sample were positive on their paired vaginal or
preputial swab, suggesting the RNA-negative cohort potentially
contains a small number of false-negative results where indivi-
duals tested negative on vaginal or preputial swab in the absence
of a urine sample (see Discussion). Thus, analysis of the PCR data
was undertaken at three levels: animal (individuals with at least
one sample type tested), urine (only individuals with a urine sam-
ple) and serum (only individuals with a serum sample).
Statistical methods
The effects of sampling date, species, sex, age, BCS, pregnancy and
lactation, and their respective interactions, on HeV antibody
prevalence, MFI and HeV RNA status were assessed, with the
exception that species were excluded from the latter as all RNA
detections were in a single species (P. alecto). Data for each vari-
able were subjected to an unbalanced generalised linear model
[35] using GenStat 2013 [36]. The binomial distribution and
logit link were adopted for binary data (HeV antibody prevalence
and RNA status) and the ln-Normal for MFI data. The initial
model included the design variables sampling event midpoint
date (sample date), age class, species, sex and the interaction
term date.age, with additional models separately adding BCS (as
a linear contrast), pregnancy and lactation (as these were corre-
lated). All models were repeated using age cohort instead of age
class. The exact binomial method for confidence intervals [37]
was adopted for zero prevalence values, as the logit estimates
here become unstable. All significance testing was conducted at
the 95% level (P < 0.05). Adjusted means (marginal, i.e. weighted
by the numbers of observations in each class) and standard errors
were estimated for each variable, along with 95% confidence inter-
vals (calculated on the logit scale and back-transformed to per-
centages). The residual plots for most variables proved to be
approximately normal. Those that showed positive skewness
and heterogeneous variance were transformed using the natural
logarithm (ln).
P. scapulatus were excluded from the serologic analysis as the
absence of a clear bimodal distribution of lnMFI values and a sub-
optimal model fit precluded robust interpretation for this species
(Text S1, Table S1, Figs S1 and S2).
Results
A total of 1968 flying-foxes were captured and sampled over the
13-month study period, comprising 1012 P. alecto, 742 P. polioce-
phalus and 214 P. scapulatus (Fig. S3). PCR results were obtained
for all individuals; serology results were obtained for 1906 indivi-
duals (967 P. alecto, 734 P. poliocephalus, 205 P. scapulatus).
Model outputs and sample sizes of variables significantly asso-
ciated with HeV RNA detection and antibody detection are pre-
sented in Data S1, Table S2 and Table S3, respectively.
RNA prevalence
HeVRNAwas detected only inP. alecto, with 42 of 1012 individuals
(4.2%, 95% CI 3.1–5.6%) positive on one or more sample type,
including serum (11/1000), urine (26/558), vaginal and preputial
swabs (18/871), rectal swabs (8/318), nasal swabs (3/306) and
oral swabs (2/307) [12]. None of the 2013 birth cohort (∼0–7
months during the study period, n = 35) tested positive. The young-
est bats that tested positive for RNAwere sub-adults∼16months of
age (2012 birth cohort), with cohort prevalence increasing to the
end of the study when the bats were ∼19 months. Limited data
points precluded the meaningful interpretation of the 2011 cohort
(Fig. 2), but a similar temporal pattern to that seen in sub-adults was
evident in the adult cohort. RNA prevalence varied significantly
with sample date (peaking mid-year, Fig. 3a) and age class (sub-
adults > adults) in the initial model, and with BCS (poor > fair >
good), and antibody status (positive > negative) in additional mod-
els (Table 1). Of 38 bats that were RNA-positive and had matched
antibody data, 34 were antibody-positive and four were antibody-
negative. There was no association between RNA prevalence and
sex, pregnancy or lactation, although prevalence differed slightly
among adult P. alecto that were pregnant (14/195, 7.2%, 95% CI
4.3–11.7), lactating but not pregnant (3/132, 2.3%, 95% CI 0.8–
6.5) or were neither pregnant nor lactating (5/96, 5.2%, 95% CI
2.2–11.6). RNA detection in urine was positively associated with
sample date and antibody status (positive > negative), but not
BCS; RNAdetection in serumwas positively associated with sample
date, age class (sub-adult>adult) and sex (female>male), but not
BCS or antibody status. None of the 742 P. poliocephalus or the
214 P. scapulatus yielded a positive PCR result on any sample
[12], yielding theoretical upper 95% confidence intervals for infec-
tion prevalence for these species of 0.5% and 1.7%, respectively.
Antibody prevalence
HeV antibody was detected in both P. alecto (651/967) and P.
poliocephalus (421/734). Antibody prevalence varied significantly
Fig. 1. Birth cohort profiles over the study period, with sampling event midpoints and
the age of sampled animal in months indicated. c13 = 2013 birth cohort, c12 = 2012
birth cohort, c11 = 2011 birth cohort, A = adult, and includes animals borne in the
2010 and earlier birth cohorts. The dashed line indicates the October mid-point of
the annual birth pulse.
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with sample date (declining over the study period) (Fig. 3b), age
class (adult > juvenile > sub-adult), species (P. alecto > P. polioce-
phalus) and the interaction term date.age in the initial model,
and with cohort (adult > c13 > c11 > c12) and BCS (good > fair
> poor) in additional models (Table 1). For both P. alecto and
P. poliocephalus, antibody prevalence was relatively static in
adults, but more dynamic in juveniles and sub-adults as illustrated
in Figure 2 (P. alecto) and Figure 4 (P. poliocephalus). In the 2013
cohort, prevalence in both species declined by the end of the
study when these individuals were approximately 7 months of
age. In the 2012 cohort, antibody prevalence in both species
was 0% at ∼10 months of age (P. alecto 0/80, 0%, 95% CI 0.0–
4.6; P. poliocephalus 0/35, 0%, 95% CI 0.00–9.9), then increased
across the next two sample dates before fluctuating. Limited
data points for the 2011 cohort again precluded meaningful inter-
pretation. There was no association between antibody prevalence
and sex, pregnancy or lactation. In adult P. alecto, prevalence did
not differ significantly among individuals that were pregnant
(143/184, 77.7%, 95% CI 71.2–83.1), lactating but not pregnant
(105/129, 81.5%, 95% CI 73.8–87.2) vs. those that were neither
pregnant nor lactating (66/92, 71.7%, 95% CI 61.8–79.9).
Similarly, antibody prevalence in adult P. poliocephalus did not
differ significantly with pregnancy or lactation status, but was
lower than in adult P. alecto across all reproductive stages; preg-
nant (105/165, 63.6%, 95% CI 56.0–70.6.1), lactating but not
pregnant (33/57, 57.9%, 95% CI 45.0–69.8), neither pregnant
nor lactating (31/62, 50.0%, 95% CI 37.9–62.1).
Comparative summary viral RNA and antibody prevalence
data for P. alecto are presented in Table 2.
lnMFI value
A significant association was observed between lnMFI and sample
date (Table 1, Fig. 3c), age class (adult > juvenile > sub-adult),
species (P. alecto > P. poliocephalus) and the interaction term
date.age, and with cohort (adult > c13 > c11 > c12), BCS (good >
Fig. 2. Hendra virus RNA and antibody prevalence
in P. alecto, with juvenile and sub-adult data pre-
sented as birth-year cohorts. c13 bats were born
in the 2013 birth season and were ∼7 months old
at the end of the study; c12 bats were born in the
2012 birth season and were ∼8 months old at the
start of the study and ∼19 months old at the end
of the study; c11 bats were born in the 2011 birth
season and were ∼20 months old at the start of
the study, and joined the adult (a) cohort during
the study period.
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fair > poor) and RNA status (positive > negative) in additional
models. In P. alecto, lnMFI values in adults and sub-adults were
highest in winter, and in juveniles, highest in summer. There
were no significant associations with sex, pregnancy or lactation
in adult P. alecto (Fig. S4) or P. poliocephalus (Fig. S5).
In antibody-positive animals, lnMFI values were significantly
associated with sample date, age class (adult>sub-adult>juvenile),
species (P. alecto > P. poliocephalus) and sex (female > male) in
the initial model, and with cohort (c12 > adult > c13 > c11) and
RNA status (positive > negative) in additional models (Table 1,
Fig. 3c, Fig. S6). Of 11 P. alecto individuals with HeV RNA
detected in serum (seven adult females, three sub-adult females
and one sub-adult male), nine also had concurrent antibody
data, and seven also had concurrent urine RNA data. Six of the
former were antibody-positive, with high lnMFI values (mean
lnMFI = 9.7) compared to RNA-negative individuals (mean
lnMFI = 7.8) and to the majority of urine RNA-positive indivi-
duals (mean lnMFI = 9.4) (Fig. 5). The remaining three serum
RNA-positive bats (33%) were antibody-negative, compared to
only 8.7% (2/23) of urine RNA-positive bats testing antibody-
negative. Of six individuals with urine and serum RNA data
plus antibody data, four were concurrently positive across all
three tests (all adult females), one was serum RNA-positive and
antibody-positive, but urine RNA-negative (adult female), and
one was urine and serum RNA-positive, but antibody-negative
(sub-adult male).
Discussion
This study sought to identify epidemiological variables signifi-
cantly associated with HeV infection in a mixed-species colony
of free-living flying-foxes over time. With a sample size of 1968
individuals, we sought associations with both RNA status as a
measure of current infection, and antibody status and lnMFI
values as measures of past infection. To our knowledge, this is
the first study to examine concurrent serologic and molecular
data of individual flying-foxes, and thus gain an insight into
both infection and immune dynamics.
The molecular data used in this analysis has been previously
analysed in the context of routes of HeV excretion [12] and
showed that HeV RNA detection was limited to P. alecto, with
no detection in P. poliocephalus or P. scapulatus. Here, we focus
on identified epidemiological associations with HeV RNA detec-
tion in P. alecto. We found that RNA detection varied over the
year, with infection in the colony more likely in the autumn
and winter months. This finding is consistent with those of
Field et al. [9] across the broader southeast Queensland/northeast
NSW region, and with the winter clustering of equine cases in
southeast Queensland/northeast NSW [38, 39], although a tem-
poral association with infection (in flying-foxes and horses)
appears to be weaker or lacking or beyond this region. The posi-
tive association between RNA detection and sub-adults in the
2012 birth cohort is consistent with a seasonal pulse of susceptible
individuals as maternal HeV antibodies wane [40] and suggest
sub-adults may play an important role in maintaining HeV infec-
tion at a population level. This scenario has previously been
hypothesised in relation to HeV [41], and parallels exist in rela-
tion to other infectious diseases [42–44]. However, given the com-
plex nature of the system, it is likely that additional drivers (e.g.
population dynamics, environmental factors) also influence
HeV transmission in flying-foxes [9, 25].
The observed positive association between RNA detection and
antibody detection, as well as the higher lnMFI values in
RNA-positive individuals, is consistent with seroconversion dur-
ing infection (or at least before viral clearing), and with serocon-
version (and boosted lnMFI values) associated with recurring or
persistent infection. Individuals testing positive for HeV RNA
in serum were less likely to be concurrently seropositive than indi-
viduals testing positive for RNA in urine, but when they were
seropositive, they had higher lnMFI values on average. This
could suggest that in natural infections, RNA in the peripheral
circulation is indicative of very recent infection, with either insuf-
ficient time for a detectable IgG response to be mounted (sero-
negative), or rapid seroconversion to high lnMFI values
(seropositive). These findings and interpretations contrast with
earlier experimental studies which suggested that infection in
serum and urine occurred simultaneously, and that antibody
response was unpredictable and not reflective of time since infec-
tion [8]. Notwithstanding, the identified positive association
between RNA detection and lnMFI values identified here suggests
that recent/current infection provokes a strong IgG response in
both sub-adult and adult bats. While the inability of the assay
to detect IgM constrains further interpretation, it is plausible
that RNA detection in sub-adults more likely represents their
first infection, and their lnMFI values a primary response; with
increasing age, adults are more likely to have been previously
infected. More broadly, it is unclear whether the 26% adult bats
that were both RNA-negative and antibody-negative have never
been exposed to HeV, or whether they have been exposed but
did not develop (or no longer have) detectable antibodies.
Fig. 3. Model fitted Hendra virus RNA prevalence in P. alecto (a), mean anti-Hendra virus antibody prevalence in P. alecto and P. poliocephalus (b), and mean
anti-Hendra virus lnMFI in P. alecto and P. poliocephalus (c).
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Regarding the latter, it also remains unknown whether these bats
are susceptible to re-infection, or whether primary infection pro-
vides lifelong protective immunity against re-infection in the
absence of detectable antibodies, as has been suggested in other
bat-viral systems [45].
The statistical association between positive RNA status and
lower BCS in the animal-level analysis (but not the urine- or
serum-level analyses) is of unknown biological significance. It
may simply reflect correlation, with the probability of infection
temporally coincident with seasonal weight loss [46]; alternatively,
it could reflect causation, with individuals in poorer body condi-
tion more likely to become infected, or at least, more likely to
excrete virus. The latter could plausibly include a scenario of
recrudescing infection and viral shedding as body condition
declines [21, 47]. However, interpretation should consider the
possibility of a small number of individuals being misclassified
as ‘RNA-negative’ on the basis of a negative vaginal or preputial
swab where a urine sample was not available, as Edson et al.
[12] found that negative vaginal or preputial swabs under-
estimated RNA presence in urine by around 44%. Consistent
with our study, McMichael et al. [48] found a significant associ-
ation between positive HeV RNA status and lower triglyceride
levels, a biomarker which they had previously shown to correlate
with lower BCS [49], but no association in urine-only analyses
between HeV status and the majority of other biomarkers strongly
correlated with BCS.
The reverse association was found between antibody status and
BCS, with animals in poorer condition less likely to have
anti-HeV antibodies (and more likely to have lower lnMFI values)
than animals in good condition. Immune responses are energet-
ically costly; energy restriction, with or without malnutrition,
can result in suppression of the immune system and increased
infection and mortality rates [50]. While speculative, our findings
may suggest that animals in poorer body condition are less cap-
able of mounting an effective innate and/or humoral immune
response, resulting in an increasing likelihood of infection and/
or viral excretion. Kessler et al. [51] suggest that the combined
effects of habitat loss and resource provisioning are driving
changes in fruit bat feeding ecology and nutrition, and may be
associated with increasing risk of viral spillover. Interestingly,
the association between poorer body condition and a weaker sero-
logic response (in terms of both serostatus and lnMFI values) was
also observed in P. poliocephalus (data not shown) suggesting the
same mechanism may be at play, but as previously stated, HeV
RNA was not detected in this species.
The absence of any association between pregnancy or lactation
and RNA detection, antibody status or lnMFI values, respectively,
differs from previous serology-only studies. Plowright et al. [21]
detected significantly higher antibody prevalence in late preg-
nant/early lactation female little red flying foxes (P. scapulatus)
compared with males or non-reproductive females. Breed et al.
[22] detected higher antibody prevalence in pregnant and lactat-
ing spectacled flying foxes (P. conspicillatus), with titres signifi-
cantly elevated in pregnant animals. Nonetheless, we did find
two notable (and possibly linked) significant associations that
suggest the role of female bats in the ecology of HeV infection
warrants further focus; namely seropositive females had higher
lnMFI values than seropositive males, and viral RNA was more
likely to be detected in serum in females than males (Table 1).
The latter finding has also been reported in experimentally
infected P. alecto [8]. While our study had large sample sizes over-
all, high pregnancy rates in adult female bats mean that sample
sizes for non-pregnant/non-lactating controls at each time point
are limited, constraining the robust interpretation of the effect
Table 1. Variables significantly associated with molecular and serological measures of HeV infectiona in wild-caught flying-foxes sampled at Boonah in southeast
Queensland in 2012–2013













Sample size 1012 558 1000 1701 1701 1072
Sample dateb *** ** * *** *** ***
Age classb * NS * *** *** **
Speciesb *** *** ***
Sexb NS NS * NS NS ***
Date.ageb ** *
BCS ** NS NS ** *** NS
Pregnancy NS NS NS NS NS NS
Lactation NS NS NS NS NS NS




HeV RNA status *** ***
NS, not significant, *<0.05, **<0.01, ***<0.001, blank, association not tested.
aHeV RNA models included data from P. alecto only, as P. poliocephalus did not yield any PCR-positive samples. HeV antibody models included data from both P. alecto and P. poliocephalus
samples.
bInitial model variables.
Full results of all models are provided as Supplementary information.
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of sex, pregnancy and lactation from broader seasonal drivers.
Specific studies to investigate the mechanisms for such interac-
tions are warranted.
P. alecto had a higher mean antibody prevalence and lnMFI
values than did P. poliocephalus. While not unexpected given
increasing evidence that the former is a primary reservoir host,
the detection of anti-HeV antibodies in over 50% of P. poliocepha-
lus is intriguing, in that it suggests that these individuals have
been sufficiently exposed to HeV to mount a humoral response.
Yet, in a colony in which HeV is circulating, evidenced by RNA
Fig. 4. Hendra virus RNA and antibody prevalence in P.
poliocephalus, with juvenile and sub-adult data pre-
sented as birth-year cohorts. c13 bats were born in
the 2013 birth season and were ∼7 months old at the
end of the study; c12 bats were born in the 2012
birth season and were ∼8 months old at the start of
the study and ∼19 months old at the end of the
study; c11 bats were born in the 2011 birth season
and were ∼20 months old at the start of the study,
and joined the adult (A) cohort during the study period.
Table 2. Comparative Hendra virus molecular and serology findings in 967a P. alecto sampled at Boonah between June 2013 and June 2014
Animals
Numbers (%) of animals
RNA +ve, antibody +ve RNA +ve, antibody −ve RNA −ve, antibody +ve RNA −ve, antibody −ve
Adult 803 29 (3.6) 2 (0.2) 562 (70) 210 (26.2)
c11 17 2 (11.7) 0 (0) 6 (35.3) 9 (53)
c12 112 3 (2.7) 2 (1.8) 29 (25.9) 78 (69.6)
c13 35 0 (0) 0 (0) 20 (57.1) 15 (42.9)
Totals 967 34 (3.5) 4 (0.4) 617 (63.8) 312 (32.3)
aNine hundred sixty-seven P. alecto had positive results for both PCR and serology. While 734 P. poliocephalus had positive serology, none had positive PCR results, precluding their inclusion
here.
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detection in multiple P. alecto, and with nearly half the P. polio-
cephalus cohort evidently susceptible as indicated by their
antibody-negative status, viral RNA was not detected in any P.
poliocephalus over the entire study period. Given the epidemiolo-
gically ‘adequate’ contact between individuals of the two species
when co-roosting, and daily contact with potentially infectious
urine [12], plus the substantial sample size, it is highly improbable
that the zero detection in P. poliocephalus is a chance event – the
upper 95% confidence interval for the population infection rate is
0.5%. The same rationale could be applied to the lack of RNA
detection in P. scapulatus, though the argument in this species
is somewhat constrained by the smaller sample size, and the
uncertain validity of the serology in this species. Targeted studies
are required to address variable host species’ responses to henipa-
virus infection and the various hypotheses put forth below. A
plausible explanation, at least in P. poliocephalus, is that the nature
of exposure or infection may be adequate to provoke an innate
immune response and antibody production, so that the virus is
cleared without systemic viral replication and excretion; for
example, localised infection and replication of mucous mem-
branes. This scenario is consistent with arguments proposed by
Dups et al. [52] and Goldspink et al. [11] to explain the aspects
of HeV infection dynamics. An alternative interpretation is that
the antibody response detected in P. poliocephalus reflects assay
cross-reactivity with a closely related henipavirus [53]. This inter-
pretation could explain the lower lnMFI values (reflecting lower
binding specificity) observed in P. poliocephalus and the lack of
HeV RNA detection even in low BCS P. poliocephalus as dis-
cussed above. However, lower lnMFI values in P. poliocephalus
might also plausibly reflect a less efficient humoral response asso-
ciated with non-systemic infection.
The reason for a lack of a clear bimodal distribution of P. sca-
pulatus lnMFI values is unknown, however could suggest cross-
reactivity within the serological assay with an unknown
Hendra-like virus, a diverse exposure history to HeV within the
population, or less plausibly reflect the smaller sample size for
this species in this study. Cross-reactivity is a plausible explanation
for the detection of anti-HeV antibodies in P. scapulatus given the
recent detection of novel henipaviruses in this species [53] and the
repeated lack of detection of HeV RNA using a qRT-PCR specific
for HeV. Future studies aimed at isolating henipaviruses from P.
scapulatus populations are required to clarify this.
Our study is novel in its concurrent molecular and serologic
screening of a sample of 1906 bats for evidence of HeV infection,
Fig. 5. Hendra virus antibody lnMFI values in P. alecto indi-
viduals by HeV RNA detection status in serum or urine.
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and the longitudinal design has allowed us to explore and explain
within-year associations at both event and individual levels with
confidence. However, the lack of replicates over multiple years
means that inter-annual generalisations should be made with care.
Conclusion
The study has yielded significant new insights into HeV infection
and immune dynamics in flying-foxes, as well as provided add-
itional support for a number of previous hypotheses. In summary,
our findings support immunologically naïve sub-adult P. alecto
playing an important role in maintaining HeV infection at a
population level. Contrary to previous studies, we found no asso-
ciation between HeV infection and pregnancy or lactation, and
therefore no support for reproductive stress as a driver for infec-
tion or recrudescing infection associated with pregnancy. The
paradoxical serologic and molecular findings in P. poliocephalus
suggest that HeV exposure in this species may not routinely result
in systemic infection and virus excretion, or alternatively, that the
serologic findings reflect assay cross-reactivity with another heni-
pavirus. Finally, we identify an association between BCS and
infection that plausibly could support a role for immune system
competence in HeV infection in flying-foxes.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0950268819001237
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